Burst-like control of lipolysis by the sympathetic nervous system in vivo

Journal of Clinical Investigation

Volumn 111, Issue 2, 2003, Pages 257-264

  Hücking, Katrin ^a   Hamilton Wessler, Marianthe ^a   Ellmerer, Martin ^a   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUPRANOLOL; GLYCEROL;

ADRENERGIC RECEPTOR BLOCKING; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARTERIAL BLOOD; ARTICLE; CENTRAL NERVOUS SYSTEM; DOG; IN VIVO STUDY; INNERVATION; LIPOLYSIS; MALE; NONHUMAN; OSCILLATION; PRIORITY JOURNAL; TIME;

ANIMALS; BUPRANOLOL; DOGS; FASTING; FATTY ACIDS, NONESTERIFIED; GLYCEROL; LIPOLYSIS; MALE; RECEPTORS, ADRENERGIC, BETA-3; SYMPATHETIC NERVOUS SYSTEM;

EID: 0037238266     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200314466     Document Type: Article

References (56)

1. Frayn, K.N. 1998. Regulation of fatty acid delivery in vivo. Adv. Exp. Med. Biol. 441:171-179.
2. Owen, O.E., Reichard, G.A., Jr., Patel, M.S., and Boden, G. 1979. Energy metabolism in feasting and fasting. Adv. Exp. Med. Biol. 111:169-188.
3. Coppack, S.W., Jensen, M.D., and Miles, J.M. 1994. In vivo regulation of lipolysis in humans. J. Lipid Res. 35:177-193.
4. Kuzawa, C.W. 1998. Adipose tissue in human infancy and childhood: an evolutionary perspective. Am. J. Phys. Anthropol. 27(Suppl.):177-209.
5. Boden, G. 2001. Free fatty acids - the link between obesity and insulin resistance. Endocr. Pract. 7:44-51.
6. Frayn, K.N., Williams, C.M., and Arnet, P. 1996. Are increased plasma non-esterified fatty acid concentrations a risk matker for coronary heart disease and other chronic diseases? Clin. Sci. (Lond.) 90:243-253.
7. Arner, P. 1996. Regulation of lipolysis in fat cells. Diabetes Reviews. 4:450-463.
8. Getty, L., Panteleon, A.E., Mittelman, S.D., Dea, M.K., and Bergman, R.N. 2000. Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo. J. Clin. Invest. 106:421-430.
9. Schwartz, M.W., Woods, S.C., Porte, D., Jr., Seeley, R.J., and Baskin, D.G. 2000. Central nervous svstem control of food intake. Nature. 104:661-671.
10. Kim, M.S., et al. 2000. The central melanocortin system affects the hypothalamo-pituitary thytoid axis and may mediate the effect of leptin. J. Clin. Invest. 105:1005-1011.
11. Bartness, T.J., and Bamshad, M. 1998. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am. J. Physiol. 275:R1399-R1411.
12. Nonogaki, K. 2000. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia. 43:533-549.
13. Bamshad, M., Aoki, V.T., Adkison, G., Warren, W.S., and Bartness, T.J. 1998. Central nervous system origins of the sympathetic nervous system outflow to white adipose tissue. Am. J. Physiol. 275:R291-R299.
14. Shi, H., and Bartness, T.J. 2001. Neurochemical phenotype of sympathetic nervous system outflow from brain to white fat. Brain Res. Bull. 54:375-385.
15. Paschoalini, M.A., and Migliorini, R.H. 1990. Participation of the CNS in the control of FFA mobilization during fasting in rabbits. Physiol. Behav. 47:461-465.
16. Barkai, A., and Allweis, C. 1972. Effect of electrical stimulation of the hypothalamus on plasma free fatty acid concentration in cats. J. Lipid Res. 13:725-732.
17. Strosberg, A.D. 1997. Structure and function of the beta 3-adrenergic receptor. Annu. Rev. Pharmacol. Toxicol. 37:421-450.
18. Zambon, A., Hashimoto, S.I., and Brunzell, J.D. 1993. Analysis of techniques to obtain plasma measurement of levels of free fatty acids. J. Lipid Res. 34:1021-1028
19. van Cauter, E. 1988. Estimating false-positive and false-negative errors in analyses of hormonal pulsatility. Am. J. Physiol. 254:E786-E794.
20. Johnson, M.L., and Veldhuis, J.D. 1986. Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am. J. Physiol. 250:E486-E493.
21. Coppack, S.W., Persson, M., Judd, R.L., and Miles, J.M. 1999. Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo. Am. J. Physiol. 276:E233-E240.
22. Johnson, M.L., and Veldhuis, J.D. 1995. Evolution of deconvolution analysis as a hormone pulse detection method. Methods in Neuroscience. 28:1-24.
23. Shaw, W.A., Issekutz, T.B., and Issekutz, B., Jr. 1975. Interrelationship of FFA and glycerol turnovers in resting and exercising dogs. J. Appl. Physiol. 39:30-36.
24. Miles, J.M., Ellman, M.G., McClean, K.L., and Jensen, M.D. 1987. Validation of a new method for determination of free fatty acid turnover. Am. J. Physiol. 252:E431-E438.
25. Armstrong, D.T., et al. 1961. Regulation of plasma free fatty acid turnover. Am. J. Physiol. 201:9-15.
26. Eaton, R.P., Berman, M., and Steinberg, D. 1969. Kinetic studies of plasma free fatty acid and triglyceride metabolism in man. J. Clin. Invest 48:1560-1579.
27. Riemens, S.C., et al. 1998. Measurement of free fatty acid kinetics during non-equilibrium tracer conditions in man: implications for the estimation of the rate of appearance of free fatty acids. Eur. J. Clin. Invest. 28:108-114.
28. Veldhuis, J.D., Carlson, M.L., and Johnson, M.L. 1987. The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc. Natl. Acad. Sci. USA. 84:7686-7690.
29. Gasperi, M., et al. 2002. GH secretion is impaired in patients with primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 87:1961-1964.
30. Juhl, C., et al. 2002. Effects of fasting on physiologically pulsatile insulin release in healthy humans. Diabetes. 51(Suppl. 1):S255-S257.
31. Van Dam, E.W., et al. 2002. Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS. Am. J. Physiol. Endocrinol. Metab. 282:E865-E872.
32. Miller, H.I., Gold, M., and Spitzer, J.J. 1962. Removal and mobilization of individual FFA in dogs. Am. J. Physiol. 202:370-374.
33. Wolfe, R.R., and Peters, E.J. 1987. Lipolytic response to glucose infusion in human subjects. Am. J. Physiol. 252:E218-E223
34. Leibel, R.L., Hirsch, J., Berry, E.M., and Gruen, R.K. 1985. Alterations in adipocyte free fatty acid re-esterification associated with obesity and weight reduction in man. Am. J. Clin. Nutr. 42:198-206.
35. Jensen, M.D. 1999 Regional glycerol and free fatty acid metabolism before and after meal ingestion. Am. J. Physiol. 276:E863-E869.
36. 3-adrenoceptors in dog fat cells and their differential activation by catecholamines. Am. J. Physiol. 264:E403-E412.
37. Collins, S., and Surwit, R.S. 2001. The beta-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis. Recent Prog. Horm. Res. 56:309-328.
38. Carpene, C., et al. 1993. Desensitization of beta-1 and beta-2, but not beta-3, adrenoceptor-mediated lipolytic responses of adipocytes after long-term norepinephrine infusion. J. Pharmacol. Exp. Ther. 265:237-247.
39. Taouis, M., Berlan, M., Montastruc, P., and Lafontan, M. 1988. Mechanism of the lipid-mobilizing effect of alpha-2 adrenergic antagonists in the dog. J. Pharmacol. Exp. Ther. 247:1172-1180.
40. Edens, N.K., Leibel, R.L., and Hirsch, J. 1990. Mechanism of free fatty acid re-esterification in human adipocytes in vitro. J. Lipid Res. 31:1423-1431.
41. van de Borne, B.P., Montano, N., Pagani, M., Oren, R., and Somers, V.K. 1997. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation. 95:1449-1454.
42. Atgie, C., D'Allaire, F., and Bukowiecki, L.J. 1997. Role of beta1- and beta3-adrenoceptors in the regulation of lipolysis and thermogenesis in rat brown adipocytes. Am. J. Physiol. 273:C1136-C1142.
43. Boyle, P.J., et al. 1992. Role of GH in regulating nocturnal rates of lipolysis and plasma mevalonare levels in normal and diabetic humans. Am. J. Physiol. 263:E168-E172.
44. Pucci, E., Chiovato, L., and Pinchera, A. 2000. Thyroid and lipid metabolism. Int. J. Obes. Relat. Metab. Disord. 24(Suppl. 2):S109-S112.
45. Samra, J.S., Clark, M.L., Humphreys, S.M., Macdonald, I.A., and Frayn, K.N. 1996. Regulation of lipid metabolism in adipose tissue during early starvation. Am. J. Physiol. 271:E541-E546.
46. Getty, L., Richard, A.M., and Corkey, B.E. 2000. Rapid oscillatory lipolysis in isolated perifused adipocytes. Obes. Res. 8(Suppl. 1):22S. (Abstr.)
47. Cogliati, C., Magatelli, R., Montano, N., Narkiewicz, K., and Somers, V.K. 2000. Detection of low- and high-frequency rhythms in the variability of skin sympathetic nerve activity. Am. J. Physiol. Heart Circ. Physiol. 278:H1256-H1260.
48. Ando, S., et al. 1994. Postganglionic sympathetic nerve discharges can contain both central and pulse-related oscillations simultaneously in rabbits. J. Auton. Nerv. Syst. 47:189-199.
49. Kaiyala, K.J., Woods, S.C., and Schwartz, M.W. 1995. New model for the regulation of energy balance and adiposity bv the central nervous system. Am. J. Clin. Nutr. 62:1123S-1134S.
50. Bergman, R.N., et al. 2001. Central role of the adipocyte in the metabolic syndrome. J. Investig. Med. 49:119-126.
51. Rebrin, K., Steil, G.M., Getty, L., and Bergman, R.N. 1995. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 44:1038-1045.
52. Rebrin, K., Steil, G.M., Mittelman, S.D., and Bergman, R.N. 1996. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J. Clin. Invest. 98:741-749.
53. Bjorntorp, P. 1991. Metabolic implications of body fat distribution. Diabetes Care. 14:1132-1143.
54. Haynes, W.G., Morgan, D.A., Walsh, S.A., Mark, A.L., and Sivitz, W.I. 1997. Receptor-mediated regional sympathetic nerve activation by leptin. J. Clin. Invest. 100:270-278.
55. Dunbar, J.C., and Lu, H. 2000. Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions. Peptides. 21:211-217.
56. Eisner, J.R., Huecking, K., Bergman, R.N., and Dunaif, A. 2001. Free fatty acid oscillations in humans: correlation with adiposity. 83rd Annual Meeting of The Endocrine Society. Denver, Colorado, USA. 3-67.